Gainers
- Biohaven Pharmaceutical Holding Company Ltd. (NASDAQ:BHVN) shares surged 68.4% to close at $140.00 on Tuesday. Pfizer Inc (NYSE:PFE) will acquire Biohaven Pharmaceutical Holding for $148.50 per share, equivalent to $11.6 billion.
- Baosheng Media Group Holdings Limited (NASDAQ:BAOS) gained 42.3% to close at $0.74.
- Appian Corporation (NASDAQ:APPN) rose 38.6% to close at $59.62. Appian was awarded $2.036 billion in damages against Pegasystems Inc..
- Vroom, Inc. (NASDAQ:VRM) shares rose 32.4% to close at $1.43 after the company reported better-than-expected Q1 results.
- MICT, Inc. (NASDAQ:MICT) jumped 32.4% to close at $0.71 after Tingo and the company announced an agreement to merge and consolidate their operations with a combined estimated group value of $4.09 billion.
- AdaptHealth Corp. (NASDAQ:AHCO) shares gained 30% to close at $14.86 after the company reported upbeat Q1 sales and announced a $200 million buyback.
- Amesite Inc. (NASDAQ:AMST) jumped 28.5% to close at $0.6264.
- Park-Ohio Holdings Corp. (NASDAQ:PKOH) gained 27.2% to close at $12.54 after the company reported better-than-expected Q1 sales results and EPS results were higher year over year.
- CECO Environmental Corp. (NASDAQ:CECE) rose 26.1% to close at $5.36 after the company posted upbeat Q1 results and announced the purchase of Compass Water Solutions.
- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) jumped 26% to close at $11.27 following strong quarterly sales.
- FibroGen, Inc. (NASDAQ:FGEN) gained 25.8% to close at $9.99 after the company reported better-than-expected Q1 EPS results.
- Esports Technologies, Inc. (NASDAQ:EBET) gained 24.9% to close at $3.71. EBET reported revenue of approximately $19 million for the quarter ended March 31, 2022.
- Praxis Precision Medicines, Inc. (NASDAQ:PRAX) jumped 24.6% to close at $9.21 after the company reported results from its PRAX-944 Phase 2a study in essential tremor patients and reported Q1 financial results.
- Rain Therapeutics Inc. (NASDAQ:RAIN) gained 24.5% to close at $3.40. Rain Therapeutics recently posted a Q1 loss of $0.66 per share.
- Myovant Sciences Ltd. (NYSE:MYOV) jumped 24% to close at $9.65 following Q4 earnings.
- Akebia Therapeutics, Inc. (NASDAQ:AKBA) gained 23.9% to close at $0.4279 following Q1 results.
- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) rose 23.8% to close at $53.24 after reporting narrower-than-expected quarterly loss.
- Cara Therapeutics, Inc. (NASDAQ:CARA) climbed 23.8% to close at $9.22 after reporting upbeat quarterly results.
- OTR Acquisition Corp. (NASDAQ:OTRA) rose 23.7% to close at $14.25. OTR Acquisition Combination Partner Comera Life Sciences announced research collaboration with a pharmaceutical company to develop subcutaneous formulation.
- Sky Harbour Group Corporation (NASDAQ:SKYH) surged 23.5% to settle at $9.62.
- JE Cleantech Holdings Limited (NASDAQ:JCSE) gained 23.5% to settle at $9.46.
- Midatech Pharma plc (NASDAQ:MTP) jumped 23.2% to close at $0.57.
- Annexon, Inc. (NASDAQ:ANNX) gained 23.1% to settle at $3.20. Annexon posted a Q1 loss of $0.92 per share.
- Angi Inc. (NASDAQ:ANGI) jumped 22.3% to close at $4.39 following upbeat quarterly sales.
- Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) gained 22% to close at $10.03 following narrower-than-expected quarterly loss.
- Ambow Education Holding Ltd. (NYSE:AMBO) surged 21.4% to close at $0.7311.
- The Very Good Food Company Inc. (NASDAQ:VGFC) jumped 21% to close at $0.2330.
- Geron Corporation (NASDAQ:GERN) gained 20.3% to settle at $1.48 after the company reported Q1 financial results.
- OPKO Health, Inc. (NASDAQ:OPK) climbed 20.1% to close at $2.93 following Q1 results.
- Fluent, Inc. (NASDAQ:FLNT) gained 19.8% to close at $1.45 after the company reported better-than-expected Q1 EPS and sales results.
- Cyngn Inc. (NASDAQ:CYN) rose 18.6% to close at $5.04.
- Assertio Holdings, Inc. (NASDAQ:ASRT) gained 17.6% to settle at $2.21 after the company reported better-than-expected Q1 EPS and sales results.
- ShockWave Medical, Inc. (NASDAQ:SWAV) climbed 17.5% to close at $136.14 after the company reported better-than-expected Q1 results and raised its FY22 sales guidance to above analyst estimates.
- The Pennant Group, Inc. (NASDAQ:PNTG) gained 14.1% to close at $14.61 following strong quarterly results.
- Cortexyme, Inc. (NASDAQ:CRTX) gained 13.4% to close at $3.72. Cortexyme agreed to acquire privately held Novosteo, which is focused on targeted therapeutics to treat rare skeletal diseases, bone cancer and injury.
- Coupang, Inc. (NYSE:CPNG) jumped 13.2% to close at $10.58.
- Cronos Group Inc. (NASDAQ:CRON) rose 12.4% to close at $3.18 following Q1 results.
- Seagen Inc. (NASDAQ:SGEN) gained 10.7% to close at $120.48. The Board of Directors of Seagen announced that its long-time president, CEO, and chairman Clay Siegall, is on a leave of absence.
- Haemonetics Corporation (NYSE:HAE) gained 10.4% to close at $54.38 following better-than-expected quarterly results.
- LivePerson, Inc. (NASDAQ:LPSN) rose 9.3% to close at $17.82 following Q1 results.
- Cenntro Electric Group Limited (NASDAQ:CENN) rose 8.1% to close at $1.60. Nuvve Holding Corp. and Cenntro reported an alliance to accelerate adoption of commercial electric vehicles.
- Nutex Health, Inc. (NASDAQ:NUTX) rose 7.3% to close at $4.99 after declining 22% on Monday.
